Perrigo Company plc (NYSE:PRGO) Receives $35.00 Consensus PT from Brokerages

Perrigo Company plc (NYSE:PRGO) has received a consensus rating of “Hold” from the five ratings firms that are presently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $35.00.

Several research firms recently commented on PRGO. StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a research note on Monday. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Finally, Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th.

Insiders Place Their Bets

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the sale, the director now directly owns 5,409 shares in the company, valued at $152,912.43. This represents a 76.49 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Perrigo

Several hedge funds have recently bought and sold shares of the stock. Headlands Technologies LLC lifted its stake in shares of Perrigo by 1,942.0% in the 4th quarter. Headlands Technologies LLC now owns 1,409 shares of the company’s stock valued at $36,000 after acquiring an additional 1,340 shares during the last quarter. Versant Capital Management Inc purchased a new position in Perrigo in the 4th quarter worth approximately $45,000. GAMMA Investing LLC lifted its position in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock valued at $49,000 after purchasing an additional 929 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after purchasing an additional 500 shares during the period. Finally, Venturi Wealth Management LLC bought a new position in shares of Perrigo in the third quarter worth approximately $56,000. 95.91% of the stock is currently owned by institutional investors.

Perrigo Stock Performance

Shares of Perrigo stock opened at $24.31 on Friday. The business’s fifty day simple moving average is $25.39 and its 200 day simple moving average is $26.41. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo has a 12 month low of $23.14 and a 12 month high of $33.46. The firm has a market capitalization of $3.32 billion, a P/E ratio of -20.78 and a beta of 0.54.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.